About GRAIL (Galleri)
GRAIL’s Galleri is a prescription blood test that screens for a cancer signal and can suggest where it originated. An ordering clinician helps interpret the result; a positive result leads to diagnostic workup rather than a cancer diagnosis from the test alone.
Obtain a Galleri orderArrange your blood drawDiscuss the result and next steps
Offering
Galleri Multi-Cancer Early Detection Test
$949
one-time
Multi-cancer signal (cell-free DNA methylation pattern) with predicted cancer signal origin
A prescription-only, blood-based multi-cancer early detection (MCED) test; reports a qualitative cancer-signal result and, when positive, a predicted cancer signal origin. Not FDA approved or cleared; operates as a laboratory-developed test.
What’s included
Galleri
A blood test that analyzes cell-free DNA methylation patterns to report a qualitative multi-cancer signal (Cancer Signal Detected / No Cancer Signal Detected) and, on a positive result, a predicted Cancer Signal Origin.
Results
Report
The report states whether a cancer signal was detected, explains the result and sets out the next steps.
Official sample report- Results
- A cancer-signal result; a positive signal also identifies the predicted tissue of origin for follow-up.
- Access
- Web
Help
Clinician review
IncludedYour ordering clinician interprets your test result.
Collection
Arrange professional blood collection through the Galleri order; an eligible mobile draw is included.
Stories
Valerie
A cancer signal led to gallbladder surgery and treatment
Valerie felt well when she chose to take Galleri, which returned a cancer signal associated with the gallbladder. Follow-up imaging led to surgery, pathology confirmed a tumor, and she completed six months of chemotherapy with gratitude that she had investigated.
grail.comTad Carper
An unexpected cancer signal led to treatment before symptoms
Tad felt well when a Galleri test offered through a Dallas Cowboys program flagged a head-and-neck cancer signal. Follow-up confirmed stage II cancer; after surgery and radiation, he reported clear scans and returning energy while continuing to recover from treatment.
grail.comRoger Royse
A blood-test signal prompted a pancreatic cancer work-up
Roger chose Galleri after reading about early detection, and the result led to MRI and a stage II pancreatic cancer diagnosis. He underwent chemotherapy and surgery, then continued care and monitoring, grateful for the chance to act before he had recognized symptoms.
seenamagowitzfoundation.orgpampolo481
A later biopsy found a tumor after a negative screening result
In an August 2023 Mayo Clinic Connect post, this customer reported a negative Galleri result followed by an endoscopic ultrasound and biopsy that found a neuroendocrine tumor. They were preparing for a PET scan when they shared their experience.
connect.mayoclinic.orgThings to know
- Galleri is ordered as a self-pay test.
The ordering clinician helps arrange testing and follow-up; diagnostic work after a positive result is separate.
- Galleri is intended for adults at elevated cancer risk.
It is recommended for people such as adults aged 50 and older and is not recommended during pregnancy or active cancer treatment.
Alternatives
Exact Sciences · Cancerguard
An overall cancer-signal test with positive-result Care Navigation; unlike Galleri, it does not report a predicted tissue of origin.
$689
Instalab · Galleri Multi-Cancer Signal
The Galleri assay sold through Instalab, with Instalab’s ordering, collection and physician-review arrangements.
$799FAQs
What does a positive cancer signal mean?
It means follow-up is needed to check for cancer. The report gives the predicted tissue of origin to help guide that workup.
Does Galleri replace regular screening?
Continue routine screening recommended by your clinician. Galleri is an additional test.
Who helps after a positive result?
Your ordering clinician directs the workup. A GRAIL patient advocate can also help with care navigation.